Perrigo Company Announces Initial Shipments of Store Brand Omeprazo...( ALLEGAN Mich. March 4 /- Perrigo ...),Health

ALLEGAN, Mich., March 4 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has begun shipping 20 mg Omeprazole delayed released tablets to its retail customers. This product delivers the same medicine at the same dose as Prilosec OTC(R). Under terms of an agreement between Dexcel Pharma Technologies and Perrigo, Perrigo is the exclusive marketer and distributor for the store brand over-the-counter market in the United States of the Dexcel-developed and manufactured product.

Perrigo's Chairman and CEO Joseph C. Papa stated, "This is the largest launch in our 120 year history. The launch of this store brand product will potentially save consumers more than $100 million per year compared to the national brand. It will also add a key new product to our customers' store brand product lines. This is the latest example of our continuing investment in new products. As always, Perrigo is committed to making quality healthcare more affordable for the world's healthcare consumers and drive value for our shareholders."

Prilosec OTC(R) is indicated for the treatment of frequent heartburn and had estimated annual sales of approximately $750 million in all outlets.

Headquartered in Or Akiva, Israel, Dexcel Pharma Technologies, Ltd. is a privately-held, international specialty pharmaceutical company which focuses on the development, manufacture and marketing of innovative prescription, generic prescription, and OTC products, based on its proprietary drug delivery systems.

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and
'/>"/>